1 |
Shinoda, c., M. Maruyama, T. Fujishita, J. Dohkan, H Oda, K Shinoda, T. Yamada, K Miyabayashi, R Hayashi, Y. Kawagishi, T. Fujita, S. Matsui, E. Sugiyama, A Muraguchi, and M. Kobayashi. 2005. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int. J. Cancer 117, 21-31
DOI
ScienceOn
|
2 |
Iwasaki, I., H Sugiyama, S. Kanazawa, and H Hemmi. 2002. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles. Cancer Chemother. Pharmacol. 49, 438-444
DOI
ScienceOn
|
3 |
Jolly, C. and R. I. Morimoto. 2000. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl. Cancer Inst. 92, 1564-1572
DOI
ScienceOn
|
4 |
Kang, C. D., B. K. Ahn, C. S. Jeong, K. W. Kim, H. J. Lee, S. D. Yoo, B. S. Chung, and S. H Kim. 2000. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein. Exp. Cell Res. 256, 300-307
DOI
ScienceOn
|
5 |
Kim, J. H., T. H Kim, H. S. Kang, J. Ro, H. S. Kim, and S. Yoon. 2009. SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to
doxorubicin. Biochem. Biophys. Res. Commun. 387, 450-455
DOI
ScienceOn
|
6 |
Komatsu, M., T. Sumizawa, M. Mutoh, Z. S. Chen, K. Terada, T. Furukawa, X. 1. Yang, H Gao, N. Miura, T. Sugiyama, and S. Akiyama. 2000. Copper- transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 60, 1312-1316
|
7 |
McCubrey, J. A, 1. S. Steelman, S. 1. Abrams, J. T. Lee, F. Chang, F. E. Bertrand, P. M. Navolanic, D. M. Terrian, R A Franklin, A B. D' Assoro, J. 1. Salisbury, M. C. Mazzarino, F. Stivala, and M. Libra. 2006. Roles of the RAF/MEK/ERK and PI3K/PTEN/ AKT pathways in malignant transformation and drug resistance. Adv. Enzyme Regul. 46, 249-279
DOI
ScienceOn
|
8 |
Choi, C. H, H. S. Kim, O. S. Kweon, T. B. Lee, H J. You, H S. Rha, J. H Jeong, D. Y. Lim, Y. D. Min, M. S. Kim, and M. H Chung. 2000. Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines. Mol. Cells 10, 38-46
DOI
ScienceOn
|
9 |
Corry, P. M. and E. P. Armour. 2005. The heat shock response: role in radiation biology and cancer therapy. Int. J. Hyperthermia 21, 769-778
DOI
ScienceOn
|
10 |
Demirag, F., E. Unsat A Yilmaz, and A Caglar. 2005. Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma. Chest 128, 3382-3387
DOI
ScienceOn
|
11 |
Edwards, J. G, D. E. Swinson, J. 1. Jones, S. Muller, D. A Waller, and K. J. O'Byrne. 2003. Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Chest 124, 1916-1923
DOI
ScienceOn
|
12 |
Gibbons, N. B., R. W. Watson, R. N. Coffey, H. P. Brady, and J. M. Fitzpatrick. 2000. Heat-shock proteins inhibit induction of prostate cancer cell apoptosis. Prostate 45, 58-65
DOI
ScienceOn
|
13 |
Han, S. I., H. Q. Duong, J. E. Choi, T. B. Lee, C. H Kim, S. Y. Lee, H M. Jeon, S. H Shin, S. C. Lim, and H S. Kang. 2008. Hyperthermia switches glucose depletion-induced necrosis to apoptosis in A549 lung adenocarcinoma cells. Int. J. Oncol. 32, 851-860
|
14 |
Zong, W. X. and C. B. Thompson. 2006. Necrotic death as a cell fate. Genes Dev. 20, 1-15
DOI
ScienceOn
|
15 |
Han, S. I., S. Y. Oh, S. H Woo, K. H Kim, J. H Kim, H D. Kim, and H S. Kang. 2001. Implication of a small GTPase Rac1 in the activation of c-Jun N-terminal kinase and heat shock factor in response to heat shock. J. BioI. Chem. 276, 1889-1895
DOI
ScienceOn
|
16 |
Blagosklonny, M. V. 2002. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia 16, 455-462
DOI
ScienceOn
|
17 |
Brozovic, A, G Fritz, M. Christmann, J. Zisowsky, U. Jaehde, M. Osmak and B. Kaina. 2004. Long-term activation of SAPK/JNK p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int. J. Cancer 112, 974-985
DOI
ScienceOn
|
18 |
Xu, Z., Z. P. Chen, A Malapetsa, M. Alaoui-Jamali, J. Bergeron, A Monks, T. G. Myers, G. Mohr, E. A Sausville, D. A Scudiero, R Aloyz, and 1. C. Panasci. 2002. DNA repair protein levels vis-a-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program. Anticancer Drugs 13, 511-519
DOI
ScienceOn
|
19 |
Yang, H, HWang, C. J. Czura, and K J. Tracey. 2005. The cytokine activity of HMGB1. J. Leukoc. BioI. 78, 1-8
DOI
ScienceOn
|
20 |
Yang, W. 1., G. Yang-Biggs, Y. Wu, X. Ye, G. Gallos, R P. Owen, and T. S. Ravikumar. 2003. Development of cross-resistance between heat and cisplatin or hydroxyurea treatments in FaDu squamous carcinoma cells. J. Surg. Res. Ill, 143-151
|
21 |
Welch, W. J. 1992. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol. Rev. 72, 1063-1081
|
22 |
Xu, H., S. M. Choi, C. S. An, Y. D. Min, K C. Kim, K J. Kim, and C. H Choi. 2005. Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines. Biochem. Biophys. Res. Commun. 328, 618-622
DOI
ScienceOn
|
23 |
Sun, C. 1. and C. C. Chao. 2005. Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP. Mol. Pharmacol. 67, 1307-1314
DOI
ScienceOn
|
24 |
Vakkila, J. and M. T. Lotze. 2004. Inflammation and necrosis promote tumour growth. Nat. Rev. Immunol. 4, 641-648
DOI
ScienceOn
|
25 |
Taniguchi, K, M. Wada, K Kohno, T. Nakamura, T. Kawabe, M. Kawakami, K Kagotani, K Okumura, S. Akiyama and M. Kuwano. 1996. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56, 4124-4129
|
26 |
Tokuda, H, M. Niwa, H. Ito, Y. Oiso, K Kato, and O. Kozawa. 2003. Involvement of stress-activated protein kinase/c-Jun N-terminal kinase in endothelin-1-induced heat shock protein 27 in osteoblasts. Eur. J. Endocrinol. 149, 239-245
DOI
ScienceOn
|
27 |
Trieb, K, S. Lang, and R Kotz. 2000. Heat-shock protein 72 in human osteosarcoma: T -lymphocyte reactivity and cytotoxicity. Pediatr. Hematol. Oncol. 17, 355-364
DOI
ScienceOn
|
28 |
Vanden Berghe, T., M. Kalai, G. Denecker, A Meeus, X. Saelens, and P. Vandenabeele. 2006. Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal 18, 328-335
DOI
ScienceOn
|
29 |
Wang, L J. Y. Zhou, and G. S. Wu. 2007. ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells. Cancer Res. 67, 11933-11941
DOI
ScienceOn
|
30 |
Wang, Z., R Gao, Y. Huang, B. Tian, and Y. Zhou. 2009. Effects of mitogen-activated protein kinase signal pathway on heat shock protein 27 expression in human lens epithelial cells exposed to sodium salicylate in vitro. J. Huazhong Univ. Sci. Technolog. Med. Sci. 29, 377-382
DOI
ScienceOn
|
31 |
Pisani, P., D. M. Parkin, F. Bray, and J. Ferlay. 1999. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83, 870-873
DOI
ScienceOn
|
32 |
Minardi, D., G. Lucarini, A Filosa, G. Milanese, A Zizzi, R Di Primio, R Montironi, and G. Muzzonigro. 2008. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. Int. J. Immunopathol Pharmacol 21, 447-455
|
33 |
Nakamura, K, K Rokutan, N. Marui, A Aoike, and K Kawai. 1991. Induction of heat shock proteins and their implication in protection against ethanol-induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology 101, 161-166
|
34 |
Park, C. H, M. J. Lee, J. Ahn, S. Kim, H H Kim, K H. Kim, H C. Eun, and J. H Chung. 2004. Heat shock-induced matrix metalloproteinase (MMP)-l and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop. J. Invest. Dermatol. 123, 1012-1019
DOI
ScienceOn
|
35 |
Sciandra, J. J. and J. R Subjeck. 1984. Heat shock proteins and protection of proliferation and translation in mammalian cells. Cancer Res. 44, 5188-5194
|
36 |
Sekhar, K R, V. N. Sonar, V. Muthusamy, S. Sasi, A Laszlo, J. Sawani, N. Horikoshi, R Higashikubo, R G. Bristow, M. J. Borrelli, P. A Crooks, J. R Lepock, J. 1. Roti Roti, and M. 1. Freeman. 2007. Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathway. Cancer Res. 67, 695-701
DOI
ScienceOn
|